Safety and Preliminary Diagnostic Performance of [⁶⁴Cu]Cu-RAX301 in Prostate Cancer
Clinical trial NCT07765940 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07765940
- Sponsor
- RadAlliance Therapeutics, Inc
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-15
- Primary completion
- 2027-06-30
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.